Importance of Receptor-targeted Systems in the Battle Against Atherosclerosis
Elisabet Rosas, Igor Sobenin, Alexander Orekhov, Elazer R. Edelman and Mercedes Balcells
Pages 5897-5903 (7)
Atherosclerosis is the leading cause of death in the Western World and has been for decades a field of intense research. Yet,
while there is a rich and diverse literature describing in detail the players and mechanisms involved in this complex disease in cell and
animal models, we remain today with virtually no reliable markers for early diagnosis and targeted treatments options. This review is
centered upon the latter. We summarize the latest studies focused on detecting endothelial dysfunction during the early stages of atherosclerosis,
when the disease is asymptomatic and describe strategies recently proposed to image and target advanced plaque.
Atherosclerosis, biomarkers, endothelial cells, receptors, early diagnosis, direct targeting.
Massachusetts Institute of Technology, Harvard-MIT Biomedical Engineering Center, 77 Massachusetts Avenue, E25-438, Cambridge, MA 02139, US.